FIGURE 1
FROM:
Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients
T Nousiainen, E Jantunen, E Vanninen and J Hartikainen
BACK TO ARTICLEFigure 1.

Changes in left ventricular ejection (LVEF) during doxorubicin therapy. (A) represents data of all patients, and (B) represents data without and with the decrease in LVEF
10% units to the final LVEF
50%. *P<0.05, ** P<0.01, ***P<0.001 vs baseline.
